NHGRI logo

A doctoral fellowship cosponsored by the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI) and the Food and Drug Administration (FDA), Office of Minority Health and Health Equity (OMHHE) is currently available.

Position Description

The newly established Genomic Science and Health Equity Fellowship Program will fund this doctoral fellowship. This program will prepare fellows to use genetic, genomic and pharmacogenomic approaches to advance minority health and health equity. Fellows will be trained in the research methodology and medical product development processes that facilitate the delivery of drugs, biologics and devices from the bench to the bedside. This fellowship program will provide fellows opportunities based upon the research conducted in the laboratories of the fellowship mentors to address basic, clinical, or social and behavioral research related to minority health and health disparities. The fellowship also strives to train a diverse group of scientists who engage in such genetic, genomic or pharmacogenomic research. The fellowship provides an opportunity to develop an interdisciplinary skill set that bridges disparities in minority health and translation of genomic, genetic and pharmacogenomic laboratory research in practice.

David Bodine, Ph.D. (NHGRI), Maria Rios, Ph.D. (FDA) and Kamille West, M.D. (NIH Clinical Center) will co-mentor the first fellow selected for this position. The fellow will pursue genomics research related to transfusion support for sickle cell disease (SCD), a health disparity condition that primarily affects African Americans in the United States.  The successful candidate will complete a research project to produce reference reagents for blood group genotyping, which will optimize transfusion support for patients with SCD.

  • Position Description

    The newly established Genomic Science and Health Equity Fellowship Program will fund this doctoral fellowship. This program will prepare fellows to use genetic, genomic and pharmacogenomic approaches to advance minority health and health equity. Fellows will be trained in the research methodology and medical product development processes that facilitate the delivery of drugs, biologics and devices from the bench to the bedside. This fellowship program will provide fellows opportunities based upon the research conducted in the laboratories of the fellowship mentors to address basic, clinical, or social and behavioral research related to minority health and health disparities. The fellowship also strives to train a diverse group of scientists who engage in such genetic, genomic or pharmacogenomic research. The fellowship provides an opportunity to develop an interdisciplinary skill set that bridges disparities in minority health and translation of genomic, genetic and pharmacogenomic laboratory research in practice.

    David Bodine, Ph.D. (NHGRI), Maria Rios, Ph.D. (FDA) and Kamille West, M.D. (NIH Clinical Center) will co-mentor the first fellow selected for this position. The fellow will pursue genomics research related to transfusion support for sickle cell disease (SCD), a health disparity condition that primarily affects African Americans in the United States.  The successful candidate will complete a research project to produce reference reagents for blood group genotyping, which will optimize transfusion support for patients with SCD.

Qualifications

To be eligible for postdoctoral training at the NIH and FDA, by May 2021, candidates must hold or obtain a Ph.D., M.D., Pharm.D. or D.V.M. in medicine, human genetics, genomics, computational biology, cell or molecular biology, epidemiology, biostatistics or closely related areas and have fewer than five years of relevant research experience since receipt of their most recent doctoral degree. Strong laboratory skills and some knowledge of statistics are required. Excellent communication skills and fluency in both spoken and written English are imperative.

  • Qualifications

    To be eligible for postdoctoral training at the NIH and FDA, by May 2021, candidates must hold or obtain a Ph.D., M.D., Pharm.D. or D.V.M. in medicine, human genetics, genomics, computational biology, cell or molecular biology, epidemiology, biostatistics or closely related areas and have fewer than five years of relevant research experience since receipt of their most recent doctoral degree. Strong laboratory skills and some knowledge of statistics are required. Excellent communication skills and fluency in both spoken and written English are imperative.

How to Apply

Interested candidates should submit their curriculum vitae, a brief statement of their research interests and the names and contact information for two professional references to Jamil B. Scott, Ph.D., M.P.H. at NHGRIFDAFellowship@nih.gov. Candidates must be a U.S. citizen or a permanent resident to apply.

Applications will be accepted starting February 15, 2021, and will be screened on a rolling basis until the position is filled. The fellow is expected to start in summer or fall 2021.

This position is subject to a background investigation. The NIH is dedicated to building a diverse community in its training and employment programs.

  • How to Apply

    Interested candidates should submit their curriculum vitae, a brief statement of their research interests and the names and contact information for two professional references to Jamil B. Scott, Ph.D., M.P.H. at NHGRIFDAFellowship@nih.gov. Candidates must be a U.S. citizen or a permanent resident to apply.

    Applications will be accepted starting February 15, 2021, and will be screened on a rolling basis until the position is filled. The fellow is expected to start in summer or fall 2021.

    This position is subject to a background investigation. The NIH is dedicated to building a diverse community in its training and employment programs.

Last updated: February 1, 2021